Van Scott award and Frost lectureship

The Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture was created in 2007 through a generous contribution from Phillip Frost, MD, FAAD. This award recognizes outstanding contributions in the treatment of skin diseases and conditions. The selected recipient receives a cash award in the amount of $15,000 and an additional $10,000 for the Phillip Frost Leadership Lecture, which the recipient will present during the plenary session at the Academy's Annual Meeting.

About Phillip Frost, MD, FAAD

A generous gift to the American Academy of Dermatology by noted dermatologist Phillip Frost, MD, FAAD, has made possible the Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture.

Born in Philadelphia, Dr. Frost received his bachelor's degree in French literature from the University of Pennsylvania in 1957. Upon graduation, Frost went to New York's Albert Einstein College of Medicine on a scholarship, completing his medical studies in 1961. After medical school, Frost began his residency at the Hospital of the University of Pennsylvania and finished his training at the University of Miami, where he later went on to to become faculty.

Throughout his career, Frost made his mark on the specialty in a number of ways. In 1972, Dr. Frost founded the dermatology department at Mt. Sinai Medical Center in Miami Beach, Fla., where he served as chairman for 18 years. At present, Dr. Frost is an Emeritus Clinical Professor of Dermatology at the University of Miami.

Early on in his career, Dr. Frost was a clinical associate at the National Cancer Institute (NCI). It is there he met his lifelong mentor, Eugene J. Van Scott, MD, FAAD, who was the chief of the Dermatology Branch at the time.

Dr. Frost is not only a prominent dermatologist and philanthropist, but also has carried an entrepreneurial spirit through business affairs and investing, most notably through the acquisition of several pharmaceutical manufacturing, marketing and distribution companies, including Key Pharmaceuticals, IVAX Corp., Teva Pharmaceuticals and Opko Health.

About Eugene J. Van Scott, MD, FAAD

Dr. Van Scott's distinction in dermatology is celebrated by more than 50 years of significant and noteworthy achievements. After completing his bachelor's and medical degrees at the University of Chicago, Van Scott joined the faculty of Temple University and later Hahnemann University in Philadelphia.

For more than 15 years, Dr. Van Scott served as the branch chief for Dermatology at NCI, where he influenced Dr. Frost so greatly that Frost chose to recognize him through this honored award. Dr. Frost comments, "Dr. Van Scott was one of my early mentors at the National Institutes of Health and I always respected him greatly as a man of creativity, integrity and hard work."

Dr. Van Scott served on the Academy's Board of Directors twice and helped to form several other dermatological groups, including the National Psoriasis Foundation, the Dermatology Foundation, and the Foundation for lchthyosis and Related Skin Types. Dr. Van Scott was honored in 1972 with the prestigious Albert Lasker Clinical Medical Research Award for research in cancer chemotherapy.

Criteria

  • The recipient should have made significant contributions toward an innovative therapy of the skin with greater emphasis within the most recent five-year period.
  • The recipient will present the Phillip Frost Leadership Lecture at a future AAD Annual Meeting during the Plenary Session.

Selection process

AAD members and others are encouraged to submit nominations and/or applications. The recipient will be selected by an Academy Selection Panel and presented to the AAD Board of Directors for approval.

Description: Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture 
Questions: Valerie Thompson, Senior Manager - Community, Corporate and Philanthropic Relations
Phone: (847) 240-1427
Fax: (847) 240-1916
Email: vthompson@aad.org

Submit a nomination

Nominations submitted on or before October 15 will be considered in the current cycle. Nominations submitted after October 15 will be considered during the next cycle.